Efficacy of Efgartigimod To Treat Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): ADHERE Trial by Madaline Spencer| Published on: May 20, 2026

Efficacy of Efgartigimod To Treat Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): ADHERE Trial by Madaline Spencer| Published on: May 20, 2026 Hans Katzberg, MD, Assistant Professor of Neurology at the University of Toronto and Neurologist at Toronto General Hospital, discusses post hoc analyses from the ADHERE clinical trial in chronic inflammatory demyelinating polyneuropathy (CIDP). https://checkrare.com/efficacy-of-efgartigimod-to-treat-patients-with-chronic-inflammatory-demyelinating-polyneuropathy-cidp-adhere-trial/